RXRX
Price
$3.23
Change
+$0.12 (+3.86%)
Updated
Jun 18 closing price
Capitalization
1.71B
53 days until earnings call
Intraday BUY SELL Signals
XBIO
Price
$2.80
Change
-$0.21 (-6.98%)
Updated
Jun 18 closing price
Capitalization
6.76M
49 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RXRX vs XBIO

RXRX vs XBIO Comparison Chart in %
View a ticker or compare two or three
VS
RXRX vs. XBIO commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Hold and XBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2026
Stock price -- (RXRX: $3.11 vs. XBIO: $3.01)
Brand notoriety: RXRX and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 133% vs. XBIO: 30%
Market capitalization -- RXRX: $1.71B vs. XBIO: $6.76M
RXRX [@Biotechnology] is valued at $1.71B. XBIO’s [@Biotechnology] market capitalization is $6.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 1 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 1 green, 4 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 2 TA indicator(s) are bullish while XBIO’s TA Score has 2 bullish TA indicator(s).

  • RXRX’s TA Score: 2 bullish, 8 bearish.
  • XBIO’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, both RXRX and XBIO are a bad buy in the short-term.

Price Growth

RXRX (@Biotechnology) experienced а +2.30% price change this week, while XBIO (@Biotechnology) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

RXRX is expected to report earnings on Aug 11, 2026.

XBIO is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.71B) has a higher market cap than XBIO($6.76M). XBIO YTD gains are higher at: 38.710 vs. RXRX (-23.961). XBIO has higher annual earnings (EBITDA): -2.39M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. XBIO (7.35M). XBIO has less debt than RXRX: XBIO (153K) vs RXRX (72.4M). RXRX has higher revenues than XBIO: RXRX (65.7M) vs XBIO (3.19M).
RXRXXBIORXRX / XBIO
Capitalization1.71B6.76M25,359%
EBITDA-478.66M-2.39M19,992%
Gain YTD-23.96138.710-62%
P/E RatioN/AN/A-
Revenue65.7M3.19M2,060%
Total Cash654M7.35M8,902%
Total Debt72.4M153K47,320%
FUNDAMENTALS RATINGS
XBIO: Fundamental Ratings
XBIO
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RXRXXBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
RXRX
Daily Signal:
Gain/Loss:
XBIO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YOOV0.530.02
+4.51%
Concorde International Group Ltd.
ROIV31.200.79
+2.60%
Roivant Sciences Ltd
RSVR10.20-0.01
-0.10%
Reservoir Media
ELAB1.43-0.01
-0.69%
Pmgc Holdings Inc
BATRK51.10-0.44
-0.85%
Atlanta Braves Holdings

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with ABCL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-2.20%
ABCL - RXRX
60%
Loosely correlated
+6.88%
ABSI - RXRX
60%
Loosely correlated
+2.57%
PRME - RXRX
59%
Loosely correlated
+10.10%
CRSP - RXRX
58%
Loosely correlated
+2.06%
BEAM - RXRX
56%
Loosely correlated
+4.81%
More